Thursday, November 29, 2018

Archived Webinar - Research updates on transcranial magnetic stimulation (TMS) for ASD

For more than 20 years, researchers have been studying TMS as a potential therapy for a number of neurological and psychiatric conditions. The U.S. Food and Drug Administration (FDA) has cleared the use of TMS for the treatment of depression in adults who haven’t been helped by medication. The use of TMS for autism is an emerging area of research.

Watch the webinar here.